Safety Shot, Inc announced the launch of Safety Shot, a revolutionary patented beverage designed to expedite alcohol detoxification and enhance cognitive clarity. The West Coast launch marks the introduction of the first-ever nutraceutical functional beverage validated by research to reduce blood alcohol content (BAC) swiftly while aiding in recovery and rehydration.
Developed by industry experts and backed by comprehensive research, Safety Shot has emerged as a game-changer in the hangover remedies market. A recent study showcased the remarkable effectiveness of Safety Shot, revealing a noteworthy reduction in BAC within just 30 minutes of consumption. The average reduction in BAC percentage for those who consumed Safety Shot was an impressive 0.079% BAC/hour, compared to a mere 0.01% BAC/hour for the control group. This statistically significant result, with a p-value of .02428, has laid the foundation for a larger double-blinded placebo-controlled trial, with anticipated results slated for release in December 2023.
To celebrate this groundbreaking launch, Safety Shot invites members of the media, investors, and influencers to an exclusive event at Bogies in Westlake Village, California, at 6 PM. Attendees will have the unique opportunity to experience Safety Shot firsthand, alongside a Q&A session with the company’s management. Limited space is available, and attendance is on a first-come, first-served basis. Those interested in attending are encouraged to send their credentials to [email protected].
Safety Shot CEO Brian John expressed enthusiasm about the West Coast launch, stating, “Our presence in the Los Angeles area aligns seamlessly with our national online direct-to-consumer sales launch, accessible through our website and Amazon. We are thrilled to witness people trying Safety Shot for themselves. Having distributed thousands of Sample Cans and conducted numerous BAC tests, we believe that trying Safety Shot is the key to understanding its transformative effects. Launches in Las Vegas and Phoenix/Scottsdale are on the horizon.”
Safety Shot is at the forefront of innovation, pioneering a new product category—rapid alcohol detoxification—in the burgeoning hangover remedies market. Valued at $1.56 billion in 2020, this market is projected to grow at a CAGR of 14.6% from 2021 to 2028.
Starting December 2023, Safety Shot will be available for retail purchase at www.DrinkSafetyShot.com and www.Amazon.com. Additionally, the company plans to kick off business-to-business sales to distributors, retailers, restaurants, and bars in the first quarter of 2024.
While Safety Shot’s innovative launch has captured attention, the company’s stock experienced a sudden decline in the market today. After closing Tuesday’s trading session at $4.79, the stock initially surged to $5.67 but is currently trading at $4.04. The company remains optimistic about its future prospects and the transformative impact of Safety Shot in the burgeoning market of hangover remedies.
At the time of this publication, Safety Shot Inc stock (SHOT) has witnessed a decline.
Safety Shot Inc
Current Price: $3.93
Change : -0.86
Change (%): (-17.91%)
Volume: 32.0M
Source: Tomorrow Events Market Data
